首页> 外国专利> PHARMACEUTICAL CONTROLLED RELEASE BEADS COMPRISING FUROSEMIDE AND A FORMULATION CONTAINING SAID CONTROLLED RELEASE BEADS

PHARMACEUTICAL CONTROLLED RELEASE BEADS COMPRISING FUROSEMIDE AND A FORMULATION CONTAINING SAID CONTROLLED RELEASE BEADS

机译:包含呋喃酮化物和包含所述受控受控释放珠的配方的药物受控释放珠

摘要

The present invention relates to controlled release beads comprising a core of an insoluble or soluble inert material provided with a layer of furosemide dispersed in a hydrophilic polymer and a specific outer membrane for controlled release of the furosemide whereby the membrane comprises 1) a film former selected from ethyl cellulose and copolymerisates of acrylic and methacrylic acid esters and 2) at least one hydrophilic polymer selected from polyvinylpyrrolidone, hydroxypropyl cellulose and polyalkylene glycols; in that the amount of the outer membrane is between 35 and 65 % (w/w) based on the dry layered core; and in that the release profile of furosemide is not more than 30 % after 60 minutes, not more than 44 % after 120 minutes and more than 80 % after 360 minutes. The present invention also refers to a process for the preparation of said controlled release beads, a pharmaceutical formulation comprising said beads and the use of said beads for treatment of cardiovascular diseases such as hypertension, congestive heart failure and oedema.
机译:本发明涉及控释珠,其包含不溶性或可溶惰性材料的芯,该芯具有分散在亲水性聚合物中的速尿层和用于速释速尿的特定外膜,由此该膜包含1)选择的成膜剂。 2)至少一种选自聚乙烯基吡咯烷酮,羟丙基纤维素和聚亚烷基二醇的亲水性聚合物;以及由乙基纤维素与丙烯酸和甲基丙烯酸酯的共聚产物和2)的至少一种亲水聚合物。基于外层干芯,外膜的量为35%至65%(w / w);速尿的释放曲线在60分钟后不超过30%,在120分钟后不超过44%,在360分钟后不超过80%。本发明还涉及制备所述控释珠粒的方法,包含所述珠粒的药物制剂以及所述珠粒在治疗心血管疾病例如高血压,充血性心力衰竭和水肿中的用途。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号